Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Assets (2016 - 2025)

Historic Return on Assets for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to 0.28%.

  • Agios Pharmaceuticals' Return on Assets fell 8100.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year decrease of 8100.0%. This contributed to the annual value of 0.52% for FY2024, which is N/A changed from last year.
  • Per Agios Pharmaceuticals' latest filing, its Return on Assets stood at 0.28% for Q3 2025, which was down 8100.0% from 0.43% recorded in Q2 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Assets peaked at 1.32% during Q4 2021, and registered a low of 0.45% during Q2 2024.
  • In the last 5 years, Agios Pharmaceuticals' Return on Assets had a median value of 0.0% in 2022 and averaged 0.24%.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Return on Assets surged by 14800bps in 2021, and later tumbled by -11500bps in 2022.
  • Quarter analysis of 5 years shows Agios Pharmaceuticals' Return on Assets stood at 1.32% in 2021, then tumbled by -100bps to 0.0% in 2022, then crashed by -11332bps to 0.37% in 2023, then skyrocketed by 206bps to 0.39% in 2024, then crashed by -173bps to 0.28% in 2025.
  • Its last three reported values are 0.28% in Q3 2025, 0.43% for Q2 2025, and 0.41% during Q1 2025.